Takeabreak2020-08-25 21:55
$万基遗传(MYGN)$ 今年至今跌去30%+的还有$Adma生物制品(ADMA)$, $BioDelivery科学国际(BDSI)$, CRVS查看全文
chuminhua2020-05-23 23:21
5/20,FDA批准了Foundation Medicine和Myriad Genetics$万基遗传(MYGN)$ 的伴随诊断测试,用于AZ和MSD的PARP抑制剂Lynparza(olaparib),用于筛选出适合治疗的转移性去势抵抗性前列腺癌患者。查看全文
网络异常请稍后再试2020-05-12 07:12
$万基遗传(MYGN)$
2019/8/13盘后财报,MISS,8/14号暴跌43%
2019/11/4盘后财报,MISS,11/5号暴跌40%;
2020/2/6盘后财报,MISS,2/7号暴跌30%;
2020/5/5盘后财报,MISS,5/6号跌4%;
这股真是有个性啊。。。。。。查看全文
$万基遗传(MYGN)$ D - Notice of Exempt Offering of Securities Filed: 2017-11-14 AccNo: 0001713695-17-000003 Size: 17 KB 网页链接
$万基遗传(MYGN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-08 AccNo: 0001564590-17-022650 Size: 8 MB 网页链接
$万基遗传(MYGN)$ 8-K - Current report Filed: 2017-11-07 AccNo: 0001564590-17-022273 Size: 7 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$万基遗传(MYGN)$ 8-K - Current report Filed: 2017-11-02 AccNo: 0001564590-17-020980 Size: 68 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$万基遗传(MYGN)$ 美东时间 2017-11-07 盘后 披露财报,预期EPS 0.21 网页链接
$万基遗传(MYGN)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-10-12 AccNo: 0001193125-17-308382 Size: 53 KB 网页链接
$万基遗传(MYGN)$ DEF 14A - Other definitive proxy statements Filed: 2017-10-12 AccNo: 0001193125-17-308380 Size: 1 MB 网页链接
$万基遗传(MYGN)$ 8-K - Current report Filed: 2017-09-05 AccNo: 0001564590-17-018280 Size: 6 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$万基遗传(MYGN)$ 8-K - Current report Filed: 2017-09-05 AccNo: 0001564590-17-018280 Size: 6 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$万基遗传(MYGN)$ 内部交易: 2017-09-01,Director,HENDERSON JOHN T ,卖出,30000普通股, $30.30